This just a week after the collapse of the PBX:Probiotix share price has left
my entire portfolio in tatters.
Ironically, the loss of my DDDD:4D Pharma shares meant the deficit between
cost and value improved by £15,925. Unfortunately, as I lost £18,000 it's
still been a pretty bad week and most shares have fallen in value, despite the
FTSE 100 reaching an all-time high.
The deficit between cost and value now stands at £114,965, but the overall
portfolio value is only £66,038 despite a massive recent injection of cash.
It's going backwards, and after dropping consistently for the last 2 years,
that drop is now accelerating.
The biggest loser this week was the share I've just ploughed £9,000 into. JLP:Jubilee Metals fell 17% after an underwhelming production update, despite the issues affecting production already being known about, and despite them all having been resolved. My brilliant timing I'd saved so carefully for when the warrant seller should have finished selling, turned out to be utterly rubbish - again.
The biggest loser this week was the share I've just ploughed £9,000 into. JLP:Jubilee Metals fell 17% after an underwhelming production update, despite the issues affecting production already being known about, and despite them all having been resolved. My brilliant timing I'd saved so carefully for when the warrant seller should have finished selling, turned out to be utterly rubbish - again.
Despite only holding JLP:Jubilee Metals for a few weeks, I am already down by
£1,700. I should really give up!
Big drop in the cost line from writing off DDDD:4D Pharma, with value relatively flat. Injection line went up £1,000 as I got paid my first pension payment and don't need it to subsidise my 20% drop in working hours until April.
Rather depressing that it took realising a massive loss to get the deficit above the trend line.
I had far more shares in DDDD:4D Pharma here than in my ISA so lost £10,281 which more than halved my long term profits. The drop in sell value of -£1,493 includes losing the value of the DDDD:4D Pharma share value as there were no purchases to counter the losses.
Realising this loss has rocketed the deficit to just £589 so it makes this chart look great. That's a nice positive to end my worst ever week since I started.
BLU:Blue Star Capital were being pumped last week, and I'm relieved I sold
my short-term trade shares for a tiny profit as they were down 5% this week.
That's 5% of the original purchase price of my tiny holding, so it was more like 15% of the
current share price.
WHR:Warehouse REIT was one of the few magic formula shares to go up this week, and climbed 5% to recover last week's losses and go just 1% down altogether, which is all commission.
WHR:Warehouse REIT was one of the few magic formula shares to go up this week, and climbed 5% to recover last week's losses and go just 1% down altogether, which is all commission.
Share of the week is PBX:Probiotix Health which climbed 9% as it recovered
from the collapse over the last 2 weeks. It's still 67% down though. I tried
to buy some but it's no longer available for on-line trading even on AJ
Bell, which is odd given I had no problem buying before the lock-in period
ended. As a result I've abandoned buying any more as they are too difficult
to get rid of. I have 100k which is a nice holding once they recover. I'll
have to wait for them to list on AIM before I sell any.
Here's the ISA and shares portfolio after week 29 of year 8.
| Weekly Change | |||
| Cash | £17.07 | -£1,696.26 | |
| Portfolio cost | £87,812.70 | -£4,783.93 | |
| Portfolio sell value (bid price-commission) | £29,958.77 | (-65.9%) | +£1,591.78 |
| Potential profits | £22.00 | +£20.52 | |
| Yr 8 Dividends | £0 | +£0 | |
| Yr 8 Interest | £0.10 | +£0.01 | |
| Yr 8 Profit from sales | -£8,360.59 | -£7,480.20 | |
| Yr 8 projected avg monthly profit | -£1,252.69 | (-26.1%) | -£1,112.97 |
| Total Dividends | £11,768.92 | +£0 | |
| Total Interest | £0.10 | +£0.01 | |
| Total Profit from sales | £19,733.47 | -£7,480.20 | |
| Average monthly cash profit | £343.50 | (7.2%) | -£83.57 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 54% | -14% |
There's a lot going on here. Cash is down because I spent the money I was saving for PBX:Probiotix on JLP:Jubilee Metals instead. I had to when the price dropped as it's way over-done. I bought 22,159 shares at 9.59p costing £2,130.
Prior to that I baled out of my disastrous short-term trade in IQAI:IQAI and sold them for 2.93p losing £68.88 (13.6%). That was a lesson in never trying to make a fast buck on something I know nothing about. It did however liberate £436 that I could spend on JLP:Jubilee Metals.
The portfolio value actually went up if you remove the big loss from the calculation thanks to PBX:Probiotix recovering 9% and the purchase of additional shares being more than the residual value of DDDD:4D Pharma that was lost..
I lost £7,411 when I wrote off DDDD:4D Pharma, but the portfolio cost only dropped £4,783 because of the JLP purchase. There was also the loss on IQAI which resulted in losses of £7,480 altogether. This made a right mess of my Year 8 stats which will no doubt stay negative for the rest of the year, and wiped off £83 a month from my long-term profit. Miraculously I'm still making an average of 7.2%, although given my current portfolio value is down by 65% and well below the injection line, the 7.2% is a bit meaningless, unless of course my shares recover...
However - much joy and celebration to beat down the gloom of losing thousands - I got 1p interest!
Big drop in the cost line from writing off DDDD:4D Pharma, with value relatively flat. Injection line went up £1,000 as I got paid my first pension payment and don't need it to subsidise my 20% drop in working hours until April.
Rather depressing that it took realising a massive loss to get the deficit above the trend line.
The SIPP looks like this after week 377 overall and week 13 of year 8.
| Weekly Change | ||||
| Cash | £175.49 | +£0.19 | ||
| Portfolio cost | £91,214.81 | -£10,281.80 | ||
| Portfolio sell value (bid price - commission) | £34,693.07 | (-62.0%) | -£1,493.90 | |
| Potential profits | £831.74 | -£40.01 | ||
| Yr 8 Dividends | £28.05 | +£0 | ||
| Yr 8 Interest | £0.52 | +£0.19 | ||
| Yr 8 Profit from sales | -£10,349.12 | -£10,281.80 | ||
| Yr 8 projected avg monthly profit | -£3,451.64 | (-66.7%) | -£3,425.49 | |
| Total Dividends | £14,170.83 | +£0 | ||
| Total Interest | £0.77 | +£0.19 | ||
| Total Profit from sales | £10,084.63 | -£10,281.80 | ||
| Average monthly cash profit | £266.96 | (5.2%) | -£119.21 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 37% | -17% |
I had far more shares in DDDD:4D Pharma here than in my ISA so lost £10,281 which more than halved my long term profits. The drop in sell value of -£1,493 includes losing the value of the DDDD:4D Pharma share value as there were no purchases to counter the losses.
Potential profits only dropped £40 which compared to everything else felt pretty good.
Not a nice sight
As with the ISA, the reduction in deficit caused by realising the loss gets us above the trend line.
As with the ISA, the reduction in deficit caused by realising the loss gets us above the trend line.
The trading account looks like this after week 343 overall and week 31 of year 7.
Have you ever seen a more damning illustration of how crap I am at share trading? I had 2 lots of DDDD:4D Pharma and I lost the lot, as well as JLP:Jubileee Metals tanking when I have 2 lots of that as well. Based on Year 7 I'm losing over £100 a month, and my long term profit over 6.5 years is now a loss of £11 a month. Absolutely rubbish.
This chart is all over the place now. The key thing is that the cash injection line is way above both the cost and value lines, which is quite bad.
| Weekly Change | |||
| Cash | £20.24 | +£0 | |
| Portfolio cost | £1,763.50 | -£1,020.27 | |
| Portfolio sell value (bid price - commission) | £1,173.95 | (-33.4%) | -£258.72 |
| Potential profits | £0 | +£0 | |
| Year 7 Dividends | £0.00 | +£0 | |
| Year 7 Interests | £0.01 | +£0 | |
| Year 7 Profit | -£1,157.99 | -£1,020.28 | |
| Yr 7 projected avg monthly profit | -£161.77 | (-110.1%) | -£141.98 |
| Dividends | £60.10 | +£0 | |
| Interest | £0.01 | +£0 | |
| Profit from sales | -£930.69 | -£1,020.28 | |
| Average monthly cash profit | -£11.00 | -(7.5%) | -£12.90 |
| (Sold stocks profit + Dividends - Fees / Months) |
Have you ever seen a more damning illustration of how crap I am at share trading? I had 2 lots of DDDD:4D Pharma and I lost the lot, as well as JLP:Jubileee Metals tanking when I have 2 lots of that as well. Based on Year 7 I'm losing over £100 a month, and my long term profit over 6.5 years is now a loss of £11 a month. Absolutely rubbish.
Realising this loss has rocketed the deficit to just £589 so it makes this chart look great. That's a nice positive to end my worst ever week since I started.
There is a tiny speck of hope I'll get something back from DDDD:4D Pharma if they can sell the IP for enough to pay the debts, but if there is anything it will be a pittance, and I'm not holding out any hope so have written off the whole lot. If I do get anything back it will be a bonus. I've never had anything back from any other share that's gone bust though, so I don't see why this will be any different.
No comments:
Post a Comment